Belite Bio, Inc BLTE
154.19 USD +11.00 (+7.68%)
At closeNov 6, 2026, 4:00 PM EST
154.19 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
141.00 Day range 155.80
105.76 52-week range 193.61
- YTD
- -3.61%
- 1 year
- +38.00%
News
globenewswire.com Belite Bio to Host Webcast on November 12, 2026, to Discuss Third Quarter 2026 Financial Results SAN DIEGO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics…
benzinga.com Belite Bio Wins Nasdaq Global Select Listing, Trading Starts Oct. 19 Belite Bio, Inc (NASDAQ:BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have
benzinga.com Belite Bio Files Marketing Authorization Application In Singapore, U.K., Switzerland For Tinlarebant To Treat Stargardt Disease Type 1 Belite Bio, Inc (NASDAQ: BLTE) ("Belite Bio®" or the "Company"), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have